Changes of insulin receptors in high fat and high glucose diet mice with insulin resistance

References

• Page MM, Johnson JD. Mild suppression of hyperinsulinemia to treat obesity and insulin resistance. Trends Endocrinol Metab. 2018;29(6):389–10. doi: 10.1016/j.tem.2018.03.018
   PubMed Web of Science ®Google Scholar
• Armandi A, Rosso C, Caviglia GP, et al. Insulin resistance across the spectrum of nonalcoholic fatty liver disease. Metabolites. 2021;11(3):155. doi: 10.3390/metabo11030155
   PubMed Web of Science ®Google Scholar
• Garcia-Ruiz C, Baulies A, Mari M, et al. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence? Free Radic Res. 2013;47(11):854–868. doi: 10.3109/10715762.2013.830717
   PubMed Web of Science ®Google Scholar
• Eckstein SS, Weigert C, Lehmann R. Divergent roles of IRS (insulin receptor Substrate) 1 and 2 in liver and skeletal muscle. Curr Med Chem. 2017;24(17):1827–1852. doi: 10.2174/0929867324666170426142826
   PubMed Web of Science ®Google Scholar
• Liu S, Zheng F, Cai Y, et al. Effect of long-term exercise training on lncRnas expression in the vascular injury of insulin resistance. J Cardiovasc Transl Res. 2018;11(6):459–469. doi: 10.1007/s12265-018-9830-0
   PubMed Web of Science ®Google Scholar
• Asai A, Chou PM, Bu HF, et al. Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice. Am J Physiol Gastrointest Liver Physiol. 2014;306(6):G496–504. doi: 10.1152/ajpgi.00291.2013
   PubMed Web of Science ®Google Scholar
• Saiful I, Shahinul A. Nonalcoholic fatty liver disease: role of insulin resistance and genetic polymorphism.Journal of clinical and experimental hepatology. J Clin Exp Hepatol. 2018;8(8):S43–S44. doi: 10.1016/j.jceh.2018.06.349
   Google Scholar
• Norman NJ, Ghali J, Radzyukevich T, et al. An Exercise‐Driven, insulin‐Independent glucose uptake pathway in contracting skeletal muscle. FASEB J. 2022;36(S1). doi: 10.1096/fasebj.2022.36.S1.R5513
   Google Scholar
• Blachnio-Zabielska A, Grycel S, Chacinska M, et al. The role of adipose tissue and excess of fatty acids in the induction of insulin resistance in skeletal muscle. Postepy Higieny i Medycyny Doswiadczalnej. 2016;70:1142–1149. doi: 10.5604/17322693.1224257
   Web of Science ®Google Scholar
• Basnet J, Rezq S, Huffman AM, et al. High‐fat diet exacerbates androgen‐Mediated obesity and white adipose tissue hypertrophy in a mouse model of polycystic ovary syndrome. FASEB J. 2022;36(S1). doi: 10.1096/fasebj.2022.36.S1.R3899
   Google Scholar
• Wang J, Wu D, Guo H, et al. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci. 2019;236(116940):116940. doi: 10.1016/j.lfs.2019.116940
   PubMedGoogle Scholar
• Barber TM, Hanson P, Weickert MO, et al. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019;13(1179558119874042):117955811987404. doi: 10.1177/1179558119874042
   Google Scholar
• Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980;50(1):113–116. doi: 10.1210/jcem-50-1-113
   PubMed Web of Science ®Google Scholar
• Eto E, Tani K, Maki J, et al. Obesity’s influence on insulin resistance in pregnant women with polycystic ovary syndrome. Acta Med Okayama. 2022;76(1):51–56. doi: 10.18926/AMO/63209
   PubMed Web of Science ®Google Scholar
• Pateguana NB, Janes A. The contribution of hyperinsulinemia to the hyperandrogenism of polycystic ovary syndrome. J Insul Resist. 2019;4(1):e1–e3. doi: 10.4102/jir.v4i1.50
   Google Scholar
• He J, Zhang J, Dong L, et al. dihydromyricetin attenuates metabolic syndrome and improves insulin sensitivity by upregulating insulin receptor substrate-1 (Y612) tyrosine phosphorylation in db/db mice. DMSO. 2019;Volume 12:12(2237–2249. doi: 10.2147/DMSO.S218487
   Google Scholar
• Zhang Y, Wang H, Zhang L, et al. Codonopsis lanceolata polysaccharide CLPS alleviates high fat/high sucrose diet-induced insulin resistance via anti-oxidative stress. Int j biol macromol. 2020;145:944–949. doi: 10.1016/j.ijbiomac.2019.09.185
   PubMed Web of Science ®Google Scholar
• Ader M, Bergman RN. Hyperinsulinemic Compensation for insulin resistance Occurs Independent of Elevated Glycemia in male dogs. Endocrinology. 2021;162(9):bqab119. doi: 10.1210/endocr/bqab119
   PubMed Web of Science ®Google Scholar
• Holland WL, Knotts TA, Chavez JA, et al. Lipid mediators of insulin resistance. Nut Rev. 2007;65(6):S39–46. doi: 10.1301/nr.2007.jun.S39-S46
   PubMed Web of Science ®Google Scholar
• Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010;375(9733):2267–2277. doi: 10.1016/S0140-6736(10)60408-4
   PubMed Web of Science ®Google Scholar
• Zeng X, Xie YJ, Liu YT, et al. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214–221. doi: 10.1016/j.cca.2019.11.003
   PubMed Web of Science ®Google Scholar
• Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840–846. doi: 10.1038/nature05482
   PubMed Web of Science ®Google Scholar
• Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148(5):852–871. doi: 10.1016/j.cell.2012.02.017
   PubMed Web of Science ®Google Scholar
• Akamine EH, Marcal AC, Camporez JP, et al. Obesity induced by high-fat diet promotes insulin resistance in the ovary. J Endocrinol. 2010;206(1):65–74. doi: 10.1677/JOE-09-0461
   PubMed Web of Science ®Google Scholar
• Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): long-term metabolic consequences. Metabolism. 2018;86:33–43. doi: 10.1016/j.metabol.2017.09.016
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030. doi: 10.1210/er.2011-1034
   PubMed Web of Science ®Google Scholar
• Oosterman JE, Wopereis S, Kalsbeek A. The Circadian Clock, shift work, and tissue-specific insulin resistance. Endocrinology. 2020;161(12):bqaa180. doi: 10.1210/endocr/bqaa180
   PubMed Web of Science ®Google Scholar
• Yazici D, Sezer H. Insulin resistance, obesity and lipotoxicity. Adv Exp Med Biol. 2017;960:277–304.
   PubMed Web of Science ®Google Scholar
• Gastaldelli A, Natali A, Vettor R, et al. Insulin resistance, adipose depots and gut: interactions and pathological implications. Dig Liver Dis. 2010;42(5):310–319. doi: 10.1016/j.dld.2010.01.013
   PubMedGoogle Scholar
• Polak K, Czyzyk A, Simoncini T, et al. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest. 2017;40(1):1–8. doi: 10.1007/s40618-016-0523-8
   PubMed Web of Science ®Google Scholar
• Park SE, Park CY, Sweeney G. Biomarkers of insulin sensitivity and insulin resistance: past, present and future. Crit Rev Clin Lab Sci. 2015;52(4):180–190. doi: 10.3109/10408363.2015.1023429
   PubMed Web of Science ®Google Scholar
• Chen SW, Zhang HM, Zhang LS, et al. Effects of soy isoflavone on gene expression of adiponectin in insulin-resistance rats induced by high-fat and high-sugar diet. Wei Sheng Yan Jiu. 2006;35(1):46–49.
   PubMedGoogle Scholar
• de Abreu VG, Martins CJM, de Oliveira PAC, et al. High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects. PLoS One. 2017;12(7):e0180947. doi: 10.1371/journal.pone.0180947
   PubMed Web of Science ®Google Scholar